 NEW YORK, July 6, 2021 PRNewswire -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Advaxis, Inc. Advaxis or the Company NASDAQ: ADXS in connection with the proposed merger of the Company with privately-held pharmaceutical development company, Biosight Ltd. Biosight. 